T2 Biosystems (TTOO) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 1, 2018 4:01 PM EDTQuarterly Product Revenue Up 71% Year-Over-Year
Reiterates 2018 Financial Guidance
LEXINGTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights and financial results for the third quarter ended September 30, 2018. Â
Third Quarter Business and Financial Performance Highlights:
Reported third quarter total revenue of $2.5 million, up 127% year-over-year.Reported third quarter product revenue of over $1.2 million, up 71%... More